These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 20298218)

  • 1. Alzheimer's disease and amyloid beta-peptide deposition in the brain: a matter of 'aging'?
    Moro ML; Collins MJ; Cappellini E
    Biochem Soc Trans; 2010 Apr; 38(2):539-44. PubMed ID: 20298218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative analysis of cortical gene expression in mouse models of Alzheimer's disease.
    Wu ZL; Ciallella JR; Flood DG; O'Kane TM; Bozyczko-Coyne D; Savage MJ
    Neurobiol Aging; 2006 Mar; 27(3):377-86. PubMed ID: 15927307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aging, gender and APOE isotype modulate metabolism of Alzheimer's Abeta peptides and F-isoprostanes in the absence of detectable amyloid deposits.
    Yao J; Petanceska SS; Montine TJ; Holtzman DM; Schmidt SD; Parker CA; Callahan MJ; Lipinski WJ; Bisgaier CL; Turner BA; Nixon RA; Martins RN; Ouimet C; Smith JD; Davies P; Laska E; Ehrlich ME; Walker LC; Mathews PM; Gandy S
    J Neurochem; 2004 Aug; 90(4):1011-8. PubMed ID: 15287908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo conversion of racemized beta-amyloid ([D-Ser 26]A beta 1-40) to truncated and toxic fragments ([D-Ser 26]A beta 25-35/40) and fragment presence in the brains of Alzheimer's patients.
    Kubo T; Nishimura S; Kumagae Y; Kaneko I
    J Neurosci Res; 2002 Nov; 70(3):474-83. PubMed ID: 12391608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isoaspartate formation and neurodegeneration in Alzheimer's disease.
    Shimizu T; Watanabe A; Ogawara M; Mori H; Shirasawa T
    Arch Biochem Biophys; 2000 Sep; 381(2):225-34. PubMed ID: 11032409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deposition of monomeric, not oligomeric, Abeta mediates growth of Alzheimer's disease amyloid plaques in human brain preparations.
    Tseng BP; Esler WP; Clish CB; Stimson ER; Ghilardi JR; Vinters HV; Mantyh PW; Lee JP; Maggio JE
    Biochemistry; 1999 Aug; 38(32):10424-31. PubMed ID: 10441137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. epsilon-Glycation, APP and Abeta in ageing and Alzheimer disease: a hypothesis.
    Schmitt HP
    Med Hypotheses; 2006; 66(5):898-906. PubMed ID: 16442744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiologic origins of age-related beta-amyloid deposition.
    Beach TG
    Neurodegener Dis; 2008; 5(3-4):143-5. PubMed ID: 18322373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etiology of sporadic Alzheimer's disease: somatostatin, neprilysin, and amyloid beta peptide.
    Hama E; Saido TC
    Med Hypotheses; 2005; 65(3):498-500. PubMed ID: 15921860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of amyloid beta peptide and pathogenesis of Alzheimer's disease. Towards presymptomatic diagnosis, prevention and therapy.
    Saido TC; Iwata N
    Neurosci Res; 2006 Apr; 54(4):235-53. PubMed ID: 16457902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The development of amyloid beta protein deposits in the aged brain.
    Thal DR; Capetillo-Zarate E; Del Tredici K; Braak H
    Sci Aging Knowledge Environ; 2006 Mar; 2006(6):re1. PubMed ID: 16525193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain.
    Güntert A; Döbeli H; Bohrmann B
    Neuroscience; 2006 Dec; 143(2):461-75. PubMed ID: 17008022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small assemblies of unmodified amyloid beta-protein are the proximate neurotoxin in Alzheimer's disease.
    Klein WL; Stine WB; Teplow DB
    Neurobiol Aging; 2004; 25(5):569-80. PubMed ID: 15172732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.
    Hardy J; Selkoe DJ
    Science; 2002 Jul; 297(5580):353-6. PubMed ID: 12130773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Redox proteomics identification of oxidatively modified proteins in Alzheimer's disease brain and in vivo and in vitro models of AD centered around Abeta(1-42).
    Sultana R; Perluigi M; Butterfield DA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Mar; 833(1):3-11. PubMed ID: 16236561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isoaspartate formation at position 23 of amyloid beta peptide enhanced fibril formation and deposited onto senile plaques and vascular amyloids in Alzheimer's disease.
    Shimizu T; Fukuda H; Murayama S; Izumiyama N; Shirasawa T
    J Neurosci Res; 2002 Nov; 70(3):451-61. PubMed ID: 12391606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor-beta signaling pathway as a therapeutic target in neurodegeneration.
    Wyss-Coray T
    J Mol Neurosci; 2004; 24(1):149-53. PubMed ID: 15314264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GM1 ganglioside and the seeding of amyloid in Alzheimer's disease: endogenous seed for Alzheimer amyloid.
    Yanagisawa K
    Neuroscientist; 2005 Jun; 11(3):250-60. PubMed ID: 15911874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An amyloid-beta protofibril-selective antibody prevents amyloid formation in a mouse model of Alzheimer's disease.
    Lord A; Gumucio A; Englund H; Sehlin D; Sundquist VS; Söderberg L; Möller C; Gellerfors P; Lannfelt L; Pettersson FE; Nilsson LN
    Neurobiol Dis; 2009 Dec; 36(3):425-34. PubMed ID: 19703562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clearance of Alzheimer's Abeta peptide: the many roads to perdition.
    Tanzi RE; Moir RD; Wagner SL
    Neuron; 2004 Sep; 43(5):605-8. PubMed ID: 15339642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.